The effect of nateglinide stimulated insulin secretion on post challenge glucose and lipid metabolism in Type 2 diabetes
Hlavní autoři: | Mohanlal, N, Holman, R |
---|---|
Médium: | Conference item |
Vydáno: |
2002
|
Podobné jednotky
-
Nateglinide, but not repaglinide, stimulates growth hormone secretion from rat pituitary cells.
Autor: Bokvist, K, a další
Vydáno: (2000) -
Effect of nateglinide on the incidence of diabetes and cardiovascular events.
Autor: Holman, R, a další
Vydáno: (2010) -
A review of nateglinide in the management of patients with type 2 diabetes
Autor: Nicholas Tentolouris, a další
Vydáno: (2008-01-01) -
Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166).
Autor: Gribble, F, a další
Vydáno: (2001) -
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
Autor: Califf, R, a další
Vydáno: (2008)